Abstract
This paper summarizes and highlights a few areas of neuropsychopharmacology. These areas of research have been selected because they have particular interest, involve the critical interaction between basic and clinical investigations, and may be relevant to the development of new drugs in the treatment of manic-depressive illness and schizophrenia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahluwahlia P, Singhal RL, (1985) Kinetics of the uptake of monoamines into synatopsomes from rat brain: consequences of lithium treatment and withdrawal. Neuropharmacology 24: 213–720
Allison JH, Blisner ME (1976) inhibition of the effect of lithium on brain inositol by atropine. Biochem Biophys Res Commun 68: 1332–1338
Allison JH, Stewart MA (1971) Reduced brain inositol in lithium treated rats. Nature New Biol 233: 267–268
Allison JH, Blisner ME, Holland WH, Hipps PP, Sherman WR (1976) Increase brain myoinositol 1-phosphate in lithium-treated rats. Biochem Biophys Res Commun 71 (2): 664– 670
Aragon MC, Herrero E, Jimenez C (1987) Effects of systematically administered lithium tryptophan transport and exchange in plasma-membrane vesicles from rat brain. Neurochem Res 12: 439–444
Asakura M, Tsukamoto T, Kubota H, Imafuku J, Ino M, Nishizaki J, Sato A, Shinbo K, Hasegawa K (1987) Role of serotonin in the regulation of beta-adrenoceptors by antidepressants. Eur J Pharmacol 141: 95–100
AvissarS, Schreiber G, Danon A, Belmaker RH (1988) Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature 331: 440–442
Balogh DW, Merritt RD (1987) Visual masking and the schizophrenic spectrum: interfacing clinical and experimental methods. Schizophr Bull 13: 679–698
Ban TA, Lohrenz JJ, Lehmann HE (1961) Observation on the action of sernyl — a new psychotrophic drug. Can J Psychiatr 6: 150–156
Baron M, Risch N, Hamburger R, Mandel B, Kushner S, Newman M, Drumer D, Belmaker RH (1987) Genetic linkage between X-chromosome markers and bipolar affective illness. Nature 326: 289–292
BassettAS, McGillivray BC, Jones BD, PantzarJT (1988) Partial trisomy chromosome 5 cosegregating with schizophrenia. Lancet 1 (8589): 799–801
Baxter LR Jr (1985) Can lithium carbonate prolong the antidepressant effect of sleep deprivation? Arch Gen Psychiatry 42: 635
Baxter LR Jr, Liston EH, Schwartz JM, Altshuler LL, Wilkins JN, Richeimer S, Guze BH (1986) Prolongation of the antidepressant response to partial sleep deprivation by lithium. Psychiatry Res 19: 17–23
Berggren U (1987) Effects of short-term lithium administration on tryptophan levels and 5- hydroxytryptamine synthesis in whole brain and brain regions in rats. J Neural Transm 69: 115–121
Berrettini WH, Nürnberger JI Jr, Scheinin M, Seppala T, Linnoila M, Narrow W, Simmons- Ailing S, Gershon ES (1985) Cerebrospinal fluid and plasma monoamines and their metabolites in euthymic bipolar patients. Biol Psychiatry 20: 257–269
Berridge MJ, Downes CP, Hanley MR (1982) Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J 206: 587–595
BlierP, De Montigny C (1985) Short-term lithium administration enhances serotonergic neurotransmission: electrophysiological evidence in the rat CNS. Eur J Pharmacol 113: 69–77
Bloom FE (1988) Neurotransmitters: past, present, and future directions. FASEB 2: 32–41
Botstein D, White RL, Skolnick M, Davis RW (1980) Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet 32: 314–331
Bowers MB, Heninger GR (1977) Lithium: clinical effects and cerebrospinal fluid acid monoamine metabolites. Commun Psychopharmacol 1: 135–145
Braff DL, Sacazzo DP (1988) The time course of information processing deficits in schizophrenia. Am J Psychiatry 142: 170–179
Brunello N, Barbaccia ML, Chuang D, Costa E (1982) Down-regulation of beta-adrenergic receptors following repeated injections of desmethylimipramine: permissive role of serotonergic axons. Neuropharmacology 21: 1145–1149
Bunney WE Jr, Garland-Bunney BL (1987) Mechanisms of action of lithium in affective illness: basic and clinical implications. In: Meitzer HY (ed) Psychopharmacology: the third generation in progress. Raven, New York, p 553–563
Campbell IC, McKernan RM, Smokcum RWJ, Stephenson JD, Weeramanthri TB (1984) Effects of desipramine, phenoxybenzamine and yohimbine on beta-adrenoceptors and cyclic AMP production in the rat brain. Neuropharmacology 23: 1385–1388
CappeliezP, White N, Duhamel JR (1982) Effect of serotonin depletion induced by p- chloroamphetamine on changes in rats’ activity levels produced by lithium. Neuropsycho- biology 8: 129–134
Carlsson A (1988) The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1: 179–186
Casebolt TL, Jope RS (1989) Chronic lithium treatment reduces norepinephrine-stimulated inositol phospholipid hydrolysis in rat cortex. Eur J Pharmacol 140: 245–246
Charney DS, Price LH, Heninger GR (1986) Desipramine-yohimbine combination treatment of refractory depression. Arch Gen Psychiatry 43: 1155–1161
Clineschmidt BV, Martin GE, Bunting PR (1982) Anticonvulsant activity of (+)-5methyl- 10,ll-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties. Drug Dev Res 2: 123–134
Collard KJ, Roberts MHT (1977) Effects of lithium on the elevation of forebrain 5-hydroxyindoles by tryptophan. Neuropharmacology 16: 671–673
Contreras PC, Di Maggio DA, O’Donohue TL (1985) Evidence for an endogenous peptide ligand and antagonist for PCP receptors. Prog Clin Biol Res 192: 495–498
Crisostomo EA, Davis JN (1985) Beta-adrenergic receptor autoradiography in rats treated with desmethylimipramine. Soc Neurosci Abstr 11: 773
Crossley DI (1984) The effects of idazoxan, an alpha-2 adrenoceptor antagonist in depression - a preliminary investigation. 9th IUPHAR congress, London, Abstract 1724 P
Crosson B, Hughes CW (1987) Role of the thalamus in language: is it related to schizophrenic thought disorder? Schizophr Bull 13: 605–621
de Montigny C, Aghajanian GJ (1978) Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science 202: 1303–1306
de Montigny C, Grunberg F, Mayer A, Deschenes J-P (1981) Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br J Psychiatry 138: 252–256
de Montigny C, Elie R, Caille G (1985) Rapid response to the addition of lithium in iprindole- resistant unipolar depression: a pilot study. Am J Psychiatry 142: 220–223
Delgado PL, Charney DS, Price LH, Landis H, Aghajanian GK, HeningerGR (1988) Behavioral effects of acute tryptophan-depletion in depressed patients. 27th American College of Neuropsychopharmacology, 11-16 Dec 1988, San Juan, Puerto Rico Detera-Wadleigh SD, Berrettini WH, Goldin LR, Boorman D, Anderson S, Gershon ES
Close linkage of c-Harvey-ras-l and the insulin gene to affective disorder is ruled out in three North American pedigrees. Nature 325:806–808
Detera-Wadleigh SD, Goldin LR, Sherrington R, Encio I, de Miguel C, Berrittini W, GurlingH, Gershon ES (1989) Exclusion of linkage to 5q 11-13 in families with schizophrenia and other psychiatric disorders. Nature: 340: 391–393
Domino EF, Kamenka JM (1988) Sigma and phencylidine-like compounds as molecular probes in biology, NPP Books, Ann Arbor MI
Dudley M, Baron M (1989) The 5HT1A site is involved in the rapid down-regulation of cortical adrenoreceptors (ß-vec.) 22nd Winter Conference on Brain Research, 21 –28 Jan 1989, Snowbird, Utah
Duman RS,Tallman JF (1988) Ontogeny and chronic antidepressant regulation of beta-1 and beta-2 adrenergic receptor messenger RNA in rat brain. Soc Neurosci Abstr, vol 14, part 2, p 1306
Dumbrille-Ross A, Tang SW (1983) Noradrenergic and serotonergic input necessary for imipramine-induced changes in beta but not S2 receptor densities. Psychiatry Res 9:207– 215
Ebstein RP, Lerer B, Shapira B, Shemesh Z, Moscovich DG, Kindler S (1988) Cyclic AMP second-messenger signal amplification in depression. Br J Psychiatry 152: 665–669
Egeland JA, Gerhard DS, Pauls DL, Sussex JN, Kidd KK, Allen CR, HostetterAM, Housman DE (1987) Bipolar affective disorders linked to DNA markers on chromosome 11. Nature 325: 783–787
Frazer A, Gudelsky G, Hartig P, Yocca F (1989) Regulation of central serotonergic responsiveness and subtypes of serotonin receptors. 22nd Winter Conference on Brain Research, 21–28 Jan 1989, Snowbird, Utah
Friedman E, Wang H-Y (1988) Effect of chronic lithium treatment on 5-hydroxytryptamine autoreceptors and release of 5-[3H]hydroxytryptamine from rat brain cortical, hippo- campal, and hypothalamic slices. J Neurochem 50: 195–201
Fyro B, Patterson V, Sedvall G (1975) The effect of lithium treatment on manic symptoms and levels of monoamine metabolites in cerebrospinal fluid of manic-depressive patients. Psychopharmacology 44: 99–103
Gelernter JE, Gejman PV, Detera-Wadleigh SD, Goldin LR, Berrittini WH, Gershon ES Restriction fragment length polymorphisms (RFLPs) show no linkage of bipolar affective disorder to the X-chromosome color blindness region in three pedigrees. 27th Annual Meeting American College of Neuropsychopharmacology 11–16 Dec 1988, San Juan, Puerto Rico
Gershon ES (1980) Genetic studies of manic-depressive illness. Pharmacopsychiatry 13:55– 61
Gershon ES, Berrettini W, Nürnberger J Jr, Goldin LR (1987) Genetics of affective illness. In: Meitzer HY (ed) Psychopharmacology the third generation in progress. Raven, New York, p481
Hallcher LM, Sherman WR (1980) The effects of lithium ion and other agents on the activity of rayo-inositol-l-phosphatase from bovine brain. J Biol Chemistry 255(22): 10896– 10901
Heal DJ, Jones SA, Buckett WR (1988) Administration of sibutramine HCl and other antidepressants including ECS decreases cortical beta-1 but not beta-2 adrenoceptors. Br J Pharmacol 94: 379
Heninger GR,Charney DS, Sternberg DE (1983) Lithium carbonate augmentation of antidepressant treatment. Arch Gen Psychiatry 40: 1335–1342
Himmelhoch JM, Detre T, Kupfer DJ, Swartzburg M, Byck R (1982) Treatment of previously intractable depressions with tranylcypromine and lithium. J Ner Ment Dis 155:216– 220
Hodgkinson S, Sherrington R, Gurling H, Marchbanks R, Redders S, Mallet J, Mclnnis M, Petursson H, Brynojolfsson J (1987) Molecular genetic evidence for heterogeneity in manic depression. Nature 325: 805–806
Hotta I, Yamawaki S (1986) Lithium decreases 5HTi receptors but increases 5-HT-sensitive adenylate cyclase activity in rat hippocampus. Biol Psychiatry 21: 1382–1390
Janowsky A, Okada F, Manier DH, Applegate CD, Sulser F, Steranka LR (1982) Role of serotonergic input in the regulation of beta-adrenergic receptor-coupled adenylate cyclase system. Science 218: 900–901
Johnson RW, Reisine T, Spotnitz S, Weich N, Ursillo R, Yamamura HI (1980) Effects of desipramine and yohimbine on alpha-2 and beta adrenoreceptor sensitivity. Eur J Pharmacol 67: 123–127
Kaufmann CA, De Lisi LE, Lehner T, Gilliam TC (1989) Physical mapping, linkage analysis of a putative schizophrenia locus on chromosome 5q. Schizophr Bull 15: 441–452
Kellar KJ (1987) Effects of electroconvulsive shock on noradrenergic and serotonergic receptors in rat brain. Pharmacopsychiatry 20: 30–34
Kellar KJ, Stockmeier CA (1986) Effects of electroconvulsive shock and serotonin axon lesions on beta-adrenergic and serotonin-2 receptors in rat brain. Ann NY Acad Sei 462: 76–90
Kendall DA, Duman R, Slopis J, Enna SJ (1982) Influence of adrenocorticotropin hormone and yohimbine on antidepressant-induced declines in rat brain neurotransmitter receptor binding and function. J Pharmacol Exp Ther 222: 566–571
Kennedy JL, Giuffra LA, Moisés HW, Cavalli-Sforza LL, Pakstis AJ, Kidd JR, Castiglione CM, Sjogren B, Wetterberg L, Kidd KK (1988) Evidence against linkage of schizophrenia to markers on chromosome 5 in a northern Swedish pedigree. Nature 336: 167–170
Klein E, Patel J, Zohar J (1987) Chronic lithium increases the phosphorylation of a 64K protein in rat brain. Brain Res 407: 312–316
Knapp S, MandellAJ (1973) Short- and long-term lithium administration: effects on the brain’s serotonergic biosynthetic systems. Science 180: 645–647
Lasagna L, Pearson JW (1965) Analgesic and psychotomimetic properties of dexoxadrol. Proc Soc Exp Biol Med 118: 352–354
Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R (1969) Study of a new schizo- phrenomimetic drug - sernyl. Arch Neurol Psychiatry 81: 113–118
Manji H, Brown JH (1987) The antidepressant effect of beta-adrenoreceptor subsensitivity: a brief review and clinical implications. Can J Psychiatry 32: 788–797
Manier DH, Gillespie DD, Steranka LR, Sulser F (1984) A pivotal role for serotonin (5HT) in the regulation of beta adrenoceptors by antidepressants: reversibility of the action of parachlorophenylalanine by 5-hydroxytryptophan. Experientia 40: 1223–1226
McDonald JW, Silverstein FS, Johnston MV (1987) MK-801 protects the neonatal brain from hypoxic-ischemic damage. Eur J Pharmacol 140: 359–361
McGhie A, Chapman JS (1961) Disorders of attention and perception in early schizophrenia. J Med Psychol 34: 103
Meitzer HY, Arora RC, Goodnick P (1983) Effect of lithium carbonate on serotonin uptake in blood platelets of patients with affective disorders. J Affective Disord 5: 215–221
Meitzer HY, Lowy M, Robertson A, Goodnick P, Perline R (1984) Effect of 5-hydroxytryptophan on serum Cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate. Arch Gen Psychiatry 41: 391–397
MendlewiczJ, FleissJL, Fieve RR (1972) Evidence for X-linkage in the transmission of manic-depressive illness. JAMA 222 (13): 1624–1627
Mendlewicz J, Simpon P, Levy S, Charon F, Brocas H, Legros S, Vassart (1987) Polymorphic DNA marker on X chromosome and manic-depression. Lancet 2: 1230–1232
Mendlewicz J et al. (1988) Molecular genetic approach in affective illness. Presented at the Collegium Internationale Neuropsychopharmacologicum, August 15–19, Munich, Germany
Menkes HA, Baraban JM, Freed AN, Snyder SH (1986) Lithium dampens neurotransmitter response in smooth muscle: relevance to action in affective illness. Proc Natl Acad Sci USA 83: 5727–5730
Minneman KP, Dibner MD, Wolfe BB, MolinoffPB (1979) Beta-1 and beta-2 adrenergic receptors in rat cerebral cortex are independently regulated. Science 204: 866–868
Naccarato F, Ray RE, Wells WW (1974) Biosynthesis of myo-inositol in rat mammary gland isolation and properties of the enzymes. Arch Biochem Biophys 164: 194–201
Nimgaonkar VL, Goodwin GM, Davies CL, Green AR (1985) Down-regulation of beta- adrenoceptors in rat cortex by repeated administration of desipramine, electroconvulsive shock and clenbuterol requires 5HT neurones but not 5HT. Neuropharmacology 24: 279–283
OlneyJ, Price M, Salles KS, LabruyereJ, Friedich G (1987) MK-801 powerfully protects against TV-methyl aspartate neurotoxicity. Eur J Pharmacol 141: 357–361
OsmanOT, Rudorfer MV, Potter WZ (1989) Idazoxan: a selective alpha-2-antagonist and effective sustained antidepressant in two bipolar depressed patients. Arch Gen Psychiatry 46: 958–959
Pandey GH, Dysken MW, Garver DL, Davis JM (1979) Beta-adrenergic receptor function in affective illness. Am J Psychiatry 135: 675–678
Patterson T, Spohn HE, Bogia DP, Hayes K (1987) Thought disorder in schizophrenia: cognitive and neuroscience approaches. Schizophr Bull 12: 460–472
Paul SM, Crews FT (1980) Rapid desensitization of cerebral beta-adrenergic receptors induced by desmethylimipramine and phenoxybenzamine. Eur J Pharmacol 62: 349–350
Perez-Cruet J, Murphy DL, Bunney WE (1971) Changes in synthesis rate of serotonin, dopamine and norepinephrine after withdrawal of chronic treatment with alpha methyl- tyrosine in rats. Clin Res 19: 735
Peroutka SJ, Conn PJ, MacDermott A, Julius D (1989) The 5-HTlc receptor: from binding site to amino acid sequence. 22nd Winter Conference on Brain Research 21–28 Jan 1989, Snowbird, Utah
Pinder RM (1985) Alpha-2-adrenoceptor antagonists as antidepressants. Drugs Future 10: 841–857
Pinder RM, SitsenJMA (1987) Alpha-2-adrenoceptor antagonists as antidepressants: the search for selectivity. In: Dahl SG, Gram LF, Paul SM, Potter WZ (eds) Clinical pharmacology in psychiatry. Springer, Berlin, Heidelberg New York, pp 107–112
PoitouP, Guerinot F, Bohuon C (1974) Effects of lithium on central metabolism of 5- hydroxytryptamine. Psychopharmacologia 38: 75–80
Price LH, ConwellY, Nelson C (1983) Lithium augmentation of combined neuroleptic- tricyclic treatment in delusion depression. Am J Psychiatry 140: 318–322
Price LH, Charney DS, Heninger G (1985) Efficacy of lithium-tranylcypromine treatment in refractory depression. Am J Psychiatry 142: 619–623
Price LH, Charney DS, Heninger GH (1986) Variability of response to lithium augmentation in refractory depression. Am J Psychiatry 143: 1387–1392
Price LH, Charney DS, Delgado PL, Heninger GR (1989) Lithium treatment and serotonergic function: neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder. Arch Gen Psychiatry 46: 13–19
Racagni G, Brunello G (1984) Transynaptic mechanisms in the action of antidepressant drugs. Trends Pharmacol Sci 5: 527–531
Rasmussen K, Aghajanian GK (1988) Potency of antipsychotics in reversing the effects of a hallucinogenic drug on locus coeruleus neurons correlates with 5-HT2 binding affinity. Neuropsychopharmacology 1:101 –107
Reich T, Clayton PJ, Winokur G (1969) Family history studies. V. The genetics of mania. Am J Psychiatry 125: 1358–1369
Reisine T, Johnson R, Wiech N, Ursillo R, Yamamura HI (1982) Rapid desensitization of central beta-receptors and up-regulation of alpha-2-receptors following antidepressant treatment. In: Costa E, Racagni G (eds) Typical and atypical antidepressants: molecular mechanisms. Raven, New York, pp 63–67
Schubert J (1973) Effects of chronic lithium treatment on monoamine metabolism in rat brain. Psychopharmacologia 32: 310–311
Scott J A, Crews FT (1983) Rapid decrease in rat brain beta adrenergic receptor binding during combined antidepressant alpha-2 antagonist treatment. J Pharmacol Exp Ther 224: 640–645
Sheard MH, Aghajanian GK (1970) Neuronally activated metabolism of brain serotonin: effect of lithium. Life Sci 9: 285–290
Sherman WR, Leavitt AL, Honchar MP, Hallcher LM, Phillips BE (1981) Evidence that lithium alters phosphoinositide metabolism: chronic administration elevate primarily wjo-inositol-1 -phosphate in cerebral cortex of the rat. J Neurochem 36: 1947–1951
Sherman WR, Gish BG, Honchar MP, Munsell LY (1986) Effects of lithium on phosphoinositide metabolism in vivo. Fed Proc 45: 2639–2646
Sherrington R, Brynjolfsson J, Petursson H, Potter M, Dudleston K, Barraclough B, WasmuthJ, Dobbs, M, Gurling H (1988) Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature 336: 164–167
Shopsin B, Gershon S, Goldstein M, Friedman E, Wilk S (1975) Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients. Psychopharmacol Commun 1: 239–249
Shopsin B, Friedman E, Gershon S (1976) Parachlorophenylalinine reversal of tranylcypromine effects in depressed patients. Arch Gen Psychiatry 33: 811–819
Shukla GS (1985) Combined lithium and valproate treatment and subsequent withdrawal: serotonergic mechanism of their interaction in discrete brain regions. Prog Neuropsycho- pharmacol Biol Psychiatry 9: 153–156
Simopoulos AM, Pinto A, Babikow PW, Kurland A, Savage C (1970) Psychotomimetic properties and therapeutic potentials of dexoxadrol on convalescing alcoholics. Dis Nerv Sys 203–207
Snider RM, Fisher SK, Agranoff BW (1987) Inositide-linked second messengers in the central nervous system. In: Meltzer HY (ed) Psychopharmacology: the third generation in Progress, Raven, New York, p 317
Snyder, SH (1987) Molecular strategies in neuropsychopharmacology: old and new. In: Meltzer HY (ed) Psychopharmacology: the third generation in progress. Raven, New York, p 17
Stockmeier CA, Martino AM, Kellar KJ (1985) A strong influence of serotonin axons on beta-adrenergic receptors in rat brain. Science 230: 323–325
Sulser F, Gillespie DD, Mirshra R, Manier DH (1984) Desensitization by antidepressants of central norepinephrine receptor systems coupled to adenylate cyclase. Ann NY Acad Sci 91–101
Swerdlow NR, Koob GF (1987) Lesions of the dorsomedial nucleus of the thalamus, medial prefrontal cortex and pedunculopontine nucleus: effects on locomotor activity mediated by nucleus accumbens-ventral pallidal circuitry. Brain Res 412: 233 - 243
Tagliamonte A, Tagliamonte P, Perez-Cruet P, Stern S, Gessa GL (1971) Effects of psychotropic drugs on tryptophan concentration in the rat brain. J Pharmacol Exp Ther 177: 475–480
Vatal M, Aiyar AS (1984) Phosphorylation of brain synaptosmal proteins in lithium-treated rats. Biochem Pharmacol 33: 829–83
Vetulani J, Sulser F (1975) Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in rat limbic forebrain. Nature 257: 495
Wang HY, Friedman E (1988) Chronic lithium: desensitization of autoreceptors mediating serotonin release. Psychopharmacology 94: 312–314
White R, Lalouel J-M (1988) Chromosome mapping with DNA markers. Sci Am 258: 4048
Wiech NL, Ursillo RC (1980) Acceleration of desipramine-induces decrease of rat cortico- cerebral beta-adrenergic receptors by yohimbine. Commun Psychopharmacol 4: 95–100
Winokur G, Tanna VL (1969) Possible role of X-linked dominant factor in manic depressivedisease. Dis Nervous Sys 30: 89–94
Worley PF, Heller WA, Snyder SH, Baraban JM (1988) Lithium blocks a phosphoinositide- mediated cholinergic response in hippocampal slices. Science 239: 1428–1429
Wu JC, Bunney WE (1990) The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am J Psychiatry 147: 14 — 21
Zhou GZ,Gong DW, Jian CC, Yao JL, Gao H, ZhuYX, Pan BS, Zhang AZ (1987) An endogenous ligand from human cerebrospinal fluid for the phencyclidine receptors. Acta Pharmacol Sin 8: 110–112
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Bunney, W.E., Bunney, B.G. (1990). A View of Psychopharmacology, Neuroscience, and the Major Psychoses. In: Bunney, W.E., Hippius, H., Laakmann, G., Schmauss, M. (eds) Neuropsychopharmacology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74034-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-74034-3_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74036-7
Online ISBN: 978-3-642-74034-3
eBook Packages: Springer Book Archive